Abstract | OBJECTIVES: METHODS: We measured serum PS-PLA1 levels in the patients with various thyroid disorders (n = 120) and normal subjects (n = 58). RESULTS: CONCLUSION: These results suggest that PS-PLA1 might be a novel target in the treatment of hyperthyroidism, especially Graves' disease, and that its measurement might be useful as a supplementary diagnostic test for thyroid function.
|
Authors | Kazuki Nakawatari, Makoto Kurano, Osamu Araki, Masako Nishikawa, Satoshi Shimamoto, Koji Igarashi, Junken Aoki, Masami Murakami, Yutaka Yatomi |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 503
Pg. 99-106
(Apr 2020)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 31978406
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier B.V. All rights reserved. |
Chemical References |
- Lysophospholipids
- Phosphatidylserines
- lysophosphatidylserine
- PLA1A protein, human
- Phospholipases A1
|
Topics |
- Adult
- Case-Control Studies
- Female
- Graves Disease
(blood)
- Humans
- Hyperthyroidism
(blood, enzymology)
- Lysophospholipids
- Male
- Middle Aged
- Phosphatidylserines
- Phospholipases A1
(blood)
|